Xencor



Ebit Zmiana Data
AbbVie USD 5.24B 1.5B 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 4.03B 11M 2024-12
Arrowhead Research USD -161412000 791K 2024-12
AstraZeneca USD 4.2B 119M 2024-12
Biogen USD 644.1M 100.9M 2024-12
Bristol-Myers Squibb USD 4.21B 500M 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
GlaxoSmithKline GBP 1.43B 1.33B 2024-12
J&J USD 5.35B 1.14B 2024-12
MacroGenics USD 54.52M 112.7M 2024-09
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Xencor USD -13178000 47.7M 2024-12



Xencor - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.